Meds A-Z
Progesterone
Detailed information about Progesterone
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For increased rate of weight gain in beef calves 45 days of age and older and weighing up to 400 lbs. This implant is not approved for repeated implantation (reimplantation) with this or any other cattle ear implant as s...
What it does:
For increased rate of weight gain in growing beef steers fed in confinement for slaughter in a reimplantation program where SYNOVEX® C or SYNOVEX® S is the first implant and a SYNOVEX® S implant is administered approxima...
When it's needed:
For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use in bull calves intended for reproduction. Safety and effective...
Call your vet sooner if you notice:
- For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use in bull calves intended for reproduction. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. This product is approved for concurrent use of dinoprost solution on day 7 of the 7-day administration period when used for the following indications: For synchronization of estrus in lactating dairy cows. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility. Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations..
Commonly reported reactions:
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Progesterone
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Zoetis Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/110315 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/9576 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use in bull calves intended for reproduction. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. This product is approved for concurrent use of dinoprost solution on day 7 of the 7-day administration period when used for the following indications: For synchronization of estrus in lactating dairy cows. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility. Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations..
- High: For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use in bull calves intended for reproduction. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. This product is approved for concurrent use of dinoprost solution on day 7 of the 7-day administration period when used for the following indications: For synchronization of estrus in lactating dairy cows. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility. Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations..
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 1 | Dog | 0 | |
| 0 | Dog | 0 |
Species coverage: Dog (2)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Dog | Non-serious | - | 1 | |
| Dog | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2018-US-026397
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 27 • Secondary summaries: 0
- ucm064927.pdf · FOI
- ucm064925.pdf · FOI
- N110315_Supp_01-22-1997.pdf · FOI
- N110315_Supp_04-05-1990.pdf · FOI
- 110-315 · EA
- 110-315 · FONSI
- Component™ E-C with Tylan™ · SPL
- Component™ E-S with Tylan™ · SPL
- Component™ E-C · SPL
- ucm049523.pdf · FOI
- UCM440503.pdf · FOI
- N009576_Supp_08_19_1994.pdf · FOI
- SYNOVEX® S · SPL
- SYNOVEX® C · SPL
- UCM388266.pdf · FOI
- UCM235348.pdf · FOI
- ucm117632.pdf · FOI
- ucm117628.pdf · FOI
- 141-200 · EA
- 141-200 · FONSI
- 141-200 · EA
- 141-200 · FONSI
- 141-200 · EA
- 141-200 · FONSI
- EAZI-BREED™ CIDR® Cattle Insert · SPL
- UCM190797.pdf · FOI
- EAZI-BREED™ CIDR® Sheep Insert · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/368 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/367 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/2571 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/2575 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadEA/161 · document · EA
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFonsi/164 · document · FONSI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1745/Component%E2%84%A2%20E-C%20with%20Tylan%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1746/Component%E2%84%A2%20E-S%20with%20Tylan%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/14466/Component%E2%84%A2%20E-C · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/283 · document · FOI
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 9, 2026, 3:15 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use in bull calves intended for reproduction. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. This product is approved for concurrent use of dinoprost solution on day 7 of the 7-day administration period when used for the following indications: For synchronization of estrus in lactating dairy cows. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility. Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations.. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 54771-1533-1 | 54771 | - | |
| 54771-3902-1 | 54771 | - | |
| 54771-3903-1 | 54771 | - | |
| 54771-3903-2 | 54771 | - | |
| 54771-5207-1 | 54771 | - | |
| 58198-0507-2 | 58198 | - | |
| 58198-0792-1 | 58198 | - | |
| 62157-485-01 | 62157 | - | |
| 73309-381-01 | 73309 | - | |
| 73377-133-01 | 73377 | - | |
| 73377-160-01 | 73377 | - | |
| 73377-160-02 | 73377 | - | |
| 73377-160-03 | 73377 | - | |
| 77382-0200-1 | 77382 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
N110315_Supp_04-05-1990.pdf
• FOI summary • Official
• July 3, 2024
FDA FOI summary for application 110315
-
N110315_Supp_01-22-1997.pdf
• FOI summary • Official
• July 3, 2024
FDA FOI summary for application 110315
-
ucm064925.pdf
• FOI summary • Official
• July 3, 2024
FDA FOI summary for application 110315
-
ucm064927.pdf
• FOI summary • Official
• July 3, 2024
FDA FOI summary for application 110315
-
N009576_Supp_08_19_1994.pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 9576
-
UCM440503.pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 9576
-
ucm049523.pdf
• FOI summary • Official
• June 15, 2023
FDA FOI summary for application 9576
-
ucm117628.pdf
• FOI summary • Official
• March 2, 2021
FDA FOI summary for application 141200
-
ucm117632.pdf
• FOI summary • Official
• March 2, 2021
FDA FOI summary for application 141200
-
UCM235348.pdf
• FOI summary • Official
• March 2, 2021
FDA FOI summary for application 141200
-
UCM388266.pdf
• FOI summary • Official
• March 2, 2021
FDA FOI summary for application 141200
-
UCM190797.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141302
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use i… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Behavioural disorder NOS. (Official, 2026-02-12)
- usage: For increased rate of weight gain in growing beef steers fed in confinement for slaughter in a reimplantation program where SYNOVEX® C or SYNOVEX® S is the fir… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Component™ E-C with Tylan™ Component™ E-S with Tylan™ Component™ E-C
RX
Estradiol Benzoate Progesterone Tylosin Tartrate
Implant
• Subcutaneous
|
Elanco US Inc. | NADA 110-315 | Approved | Jul 3, 2024 |
|
SYNOVEX® S SYNOVEX® C
OTC
Estradiol Benzoate Progesterone
Implant (Pellet)
• Subcutaneous
|
Zoetis Inc. | NADA 9576 | Approved | Jun 15, 2023 |
|
EAZI-BREED™ CIDR® Cattle Insert
OTC
Progesterone
Insert
• Intravaginal
|
Zoetis Inc. | NADA 141-200 | Approved | Mar 2, 2021 |
|
EAZI-BREED™ CIDR® Sheep Insert
OTC
Progesterone
Solid Matrix
• Intravaginal
|
Zoetis Inc. | NADA 141-302 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For increased rate of weight gain in beef calves 45 days of age and older and weighing up to 400 lbs. This implant is not approved for repeated implantation (reimplantation) with this or any other cattle ear implant as safety and effectiveness has not been evaluated.
Administer one implant containing 100 mg progesterone, 10 mg estradiol benzoate, and 29 mg tylosin tartrate (5 pellets) to each calf by subcutaneous implantation in the middle-third of the ear
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For increased rate of weight gain in growing beef steers fed in confinement for slaughter in a reimplantation program where SYNOVEX® C or SYNOVEX® S is the first implant and a SYNOVEX® S implant is administered approximately 70 days later. Other than ad described on labeling, this implant is not approved for repeated implantation (reimplantation) with any other cattle ear implant in growing beef steers fed in confinement for slaughter as safety and effectiveness have not been evaluated. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because effectiveness and safety have not been evaluated. Do not use in animals intended for subsequent breeding, or in dairy cows.
For increased rate of weight gain in beef calves 45 days of age and older and weighing up to 400 lbs: Administer one implant containing 100 mg progesterone and 10 mg estradiol benzoate (4 pellets) to each steer by subcutaneous implantation in the middle third of the ear. For increased rate of weight gain in growing beef steers fed in confinement for slaughter in a reimplantation program where SYNOVEX® C or SYNOVEX® S is the first implant and a SYNOVEX® S implant is administered approximately 70 days later: Administer one implant containing 100 mg progesterone and 10 mg estradiol benzoate (4 pellets) or one implant containing 200 mg progesterone and 20 mg estradiol benzoate (8 pellets) and administer one implant containing 200 mg progesterone and 20 mg estradiol benzoate (pellets) on approximately day 70 following initial implantation.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Administer one intravaginal insert per animal 14 +/- 1 days after insemination. Remove intravaginal insert 7 days later.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
FOI ucm064927.pdf
Summary
This supplement provides for addition to the labeling of the statements “A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.” to the warning section and “Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.” immediately following the label indications. -
FOI ucm064925.pdf
Summary
Component® E-S with Tylan®: For increased rate of weight gain and improved feed efficiency in steers weighing 400 lbs or more. -
Summary
This supplement provides for the deletion of the present labeling limitation against the use of Implus-C in heifer (suckling beef) calves intended for reproduction.
-
Summary
This supplement provides for the use of CALF-oid in suckling beef calves (at least 45 days of age) up to 400 lbs. of bodyweight.
-
EA 110-315
-
FONSI 110-315
- Component™ E-C with Tylan™ (ZIP)
- Component™ E-S with Tylan™ (ZIP)
- Component™ E-C (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm049523.pdf
Summary
This supplement provides for addition to the labeling of the statements “A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.” to the warning section and “Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.” immediately following the label indications. -
FOI UCM440503.pdf
Summary
This supplement provides for the implantation of Synovex C in steers fed in confinement for slaughter when used as part of a reimplant program where Synovex S is implanted at approximately day 70 after the initial implantation of Synovex C. -
Summary
This supplement provides for reimplantation of Synovex® S at approximately day 70 in steers fed in confinement for slaughter for additional improvement in rate of weight gain.
- SYNOVEX® S (ZIP)
- SYNOVEX® C (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM388266.pdf
Summary
This supplement provides for the addition of a new indication for induction of estrous cycles in anestrous lactating dairy cows. -
FOI UCM235348.pdf
Summary
This supplement provides for the concurrent administration of progesterone solid matrix and dinoprost tromethamine for synchronization of estrus in lactating dairy cows. -
FOI ucm117632.pdf
Summary
For synchronization of the return to estrus in lactating dairy cows inseminated at the immediately preceding estrus -
FOI ucm117628.pdf
Summary
1. Synchronization of estrus in suckled beef cows, and replacement beef and dairy heifers. 2. Advancement of first postpartum estrus in suckled beef cows. 3. Advancement of first pubertal estrus in replacement beef heifers. -
EA 141-200
-
FONSI 141-200
-
EA 141-200
-
FONSI 141-200
-
EA 141-200
-
FONSI 141-200
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM190797.pdf
Summary
For induction of estrus in ewes (sheep) during seasonal anestrus.
FDA page: Open in Animal Drugs @ FDA
Usage
For increased rate of weight gain in growing beef steers fed in confinement for slaughter in a reimplantation program where SYNOVEX® C or SYNOVEX® S is the first implant and a SYNOVEX® S implant is administered approximately 70 days later. Other than ad described on labeling, this implant is not approved for repeated implantation (reimplantation) with any other cattle ear implant in growing beef steers fed in confinement for slaughter as safety and effectiveness have not been evaluated. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because effectiveness and safety have not been evaluated. Do not use in animals intended for subsequent breeding, or in dairy cows. For increased rate of weight gain in growing beef steers fed in confinement for slaughter in a reimplantation program where SYNOVEX® C or SYNOVEX® S is the first implant and a SYNOVEX® S implant is administered approximately 70 days later. Other than as described on labeling, this implant is not approved for repeated implantation (reimplantation) with any other cattle ear implant in growing beef steers fed in confinement for slaughter as safety and effectiveness have not been evaluated. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because effectiveness and safety have not been evaluated. Do not use in animals intended for subsequent breeding, or in dairy cows. For increased rate of weight gain in beef calves 45 days of age and older and weighing up to 400 lbs. This implant is not approved for repeated implantation (reimplantation) with this or any other cattle ear implant as safety and effectiveness has not been evaluated.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
For use in suckling beef calves (at least 45 days of age) up to 400 pounds of body weight. For subcutaneous ear implantation, one dose per animal. Do not use in bull calves intended for reproduction. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. This product is approved for concurrent use of dinoprost solution on day 7 of the 7-day administration period when used for the following indications: For synchronization of estrus in lactating dairy cows. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility. Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations. Do not use in animals with abnormal, immature, or infected genital tracts; or in dairy cows that are fewer than 40 days postpartum for synchronization of estrus or synchronization of the return to estrus; or in anestrous lactating dairy cows less than 42 days or greater than 78 days postpartum for induction of estrous cycles. Do not use an insert more than once. To prevent the potential transmission of venereal and blood borne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility Product labeling shall bear the following warnings: "Avoid contact with skin by wearing protective gloves when handling inserts. Store used (removed) inserts in a plastic bag or other sealable container until they can be properly disposed in accordance with applicable local, State, and Federal regulations..
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 1 and Cat 0 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Retriever - Labrador, Male, 3 year, 45.359 kilogram • Drug: MSK, Insert, Oral • Reactions: Behavioral disorder (unspecified) • Outcome: Ongoing
- Report ID: USA-USFDACVM-2018-US-026397
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 3.00 Year
- Weight: 45.359 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Insert
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.